drugset / Trial / NCT01969058

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

NCT01969058

RandomizedParallel-groupOpen-labelTreatment

Summary

This phase II study was done in HIV-infected participants on antiretroviral therapy to evaluate the effects of isotretinoin (a drug that is approved for use in the treatment of severe acne) on the immune system. The immune system helps the body fight infections. When the immune system is not working well, one may be at greater risk for diseases that are common in aging, like heart disease, weaker bones, and kidney disease.

Timeline

Start
2014-07-02
Primary completion
2016-08-31
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isotretinoin Other / unclassified 1 mg/kg Oral